Janus International Group, Inc. financial statements

Income statement, balance sheet and cash flow statement for the last 6 fiscal years, taken from the XBRL data Janus International Group, Inc. files with the SEC in its annual reports.

In USD millions, except per-share amounts. Outflows in the cash flow statement are negative.

Income statement

	FY2021	FY2021	FY2022	FY2023	FY2024	FY2025
Revenue	549	750	1,020	1,066	964	884
Cost of revenue	345	499	655	617	566	541
Gross profit	204	251	365	450	398	343
Selling and marketing	34.5	46.3	58.3	65.5	68.1	68
General and administrative	76.9	112	119	139	171	163
Operating expenses	109	159	177	204	251	232
Operating income	94.5	92.3	188	246	147	112
Interest expense	36	32.9	42	60	49.6	36.8
Interest income			0	0	2.1	5.6
Other non-operating income	-35.6	-42	-42.2	-62.9	-46.3	-35.1
Pre-tax income	59	50.3	145	183	100	76.4
Income tax	2.11	6.5	37.6	47.1	29.9	22.6
Net income	56.8	43.8	108	136	70.4	53.8
EBITDA	101	98.8	225	285	191	158
EPS, basic	0.86	0.41	0.73	0.92	0.49	0.39
EPS, diluted	0.86	0.40	0.73	0.92	0.49	0.38
Shares, basic (weighted)	65.8	108	147	147	144	139
Shares, diluted (weighted)	65.8	109	147	147	145	140

Balance sheet

	FY2021	FY2021	FY2022	FY2023	FY2024	FY2025
Cash and equivalents	45.3	13.2	78.4	172	149	194
Receivables	75.1	107	155	174	137	108
Inventory	25.3	56.6	67.7	48.4	53.3	58.6
Other current assets	5.19	4.06	13.3	10.8	16	23.8
Total current assets	168	214	363	463	386	422
Property, plant and equipment	31	41.6	42.1	52.4	56.8	66.2
Lease right-of-use assets			43.3	47.6	56.3	70.8
Goodwill	259	369	368	369	383	384
Intangible assets		436	404	375	374	341
Other non-current assets	2.42	1.97	1.8	2.9	5.8	5.3
Total assets	873	1,122	1,271	1,350	1,301	1,305
Accounts payable	29.9	55	52.3	59.8	53.9	40.7
Accrued liabilities	37.2	13.9	1.2	0.8	13.7	14.4
Deferred revenue	21.5	23.2	21.4	26.7	17.9	16.7
Short-term debt	6.52	8.07	8.3	7.3	8.8	6.9
Total current liabilities	95.1	140	153	174	137	119
Long-term debt	618	704	700	608	583	539
Lease liabilities			40.9	46.9	56.2	70.9
Other non-current liabilities	4.63	2.53	40.9	46.9	60.8	71.3
Total liabilities	733	854	895	830	783	733
Total debt	618	712	708	615	592	546
Paid-in capital	189	278	282	289	300	316
Retained earnings	-48.2	-8.58	98.2	234	304	358
Treasury stock			0	-0.4	-81.4	-100
Other comprehensive income	-0.23	-0.95	-4.8	-2.9	-3.8	-1.1
Shareholders' equity	141	268	375	520	519	573
Total equity	141	268	375	520	519	573
Total liabilities and equity	873	1,122	1,271	1,350	1,301	1,305
Shares outstanding	66.1	147	147	147

Cash flow statement

	FY2021	FY2021	FY2022	FY2023	FY2024	FY2025
Net income	56.8	43.8	108	136	70.4	53.8
Depreciation and amortization	5.99	6.5	37.6	39.1	44	46.1
Stock-based compensation	0.17	5.3	4.1	7.1	10.7	16.2
Deferred income tax	0.35	4.8	13.5	9.5	0.1	25.4
Change in receivables	-4.93	-24	-50.1	-17.4	24.2	28.5
Change in inventory	3.57	-22.9	-10.3	19.4	-4.8	-5.4
Change in payables	0.37	16.6	-2.7	7.3	-6.1	-13.7
Cash from operations	101	74.8	88.5	215	154	140
Capital expenditures	-6.34	-19.9	-8.8	-19	-20.1	-25.5
Acquisitions	-4.47	-180	0	-1	-59.4	-0.1
Cash from investing	-10.8	-190	-8.7	-19.9	-73.1	-25.6
Share buybacks			0	0	-78.8	-15.9
Cash from financing	-64.1	82.8	-14.7	-102	-103	-69.4
Exchange rate effect	-0.6	0.2	0.1	0.6	-0.3	0.6
Net change in cash	25.3	-32.1	65.2	93.3	-22.4	45.1
Free cash flow	94.5	54.9	79.7	196	134	114
Interest paid	30.8	32.9	40.9	43.4	58.9	39.7
Income taxes paid	1.3	2.1	33.4	33.9	26.8	7.3

Key metrics

Worked out from the statements above. Latest values use the trailing twelve months to July 4, 2026; growth uses fiscal years. Valuation uses the share price of $4.21 on September 25, 2026.

Profitability

Metric	Value	How it is calculated
Gross margin	35.9%	Gross profit / revenue.
Operating margin	9.3%	Operating income / revenue.
EBITDA margin	15.4%	EBITDA (operating income + depreciation and amortization) / revenue.
Pre-tax margin	5.5%	Pre-tax income / revenue.
Net margin	3.7%	Net income / revenue.
FCF margin	9.1%	Free cash flow (cash from operations - capital expenditures) / revenue.
Operating cash flow margin	11.1%	Cash from operations / revenue.
Effective tax rate	32.9%	Income tax / pre-tax income, when pre-tax income is positive.
Return on equity (ROE)	5.8%	Net income / average shareholders' equity (opening and closing). Not shown when equity is negative.
Return on assets (ROA)	2.5%	Net income / average total assets.
Return on invested capital (ROIC)	5.7%	Approximation: operating income x (1 - tax rate) / average (total debt + equity - cash). Tax rate is the effective rate when between 0% and 50%, else 21%.
Stock-based pay / revenue	1.8%	Stock-based compensation (from the cash flow statement) / revenue.
Capex / revenue	2.0%	Capital expenditures / revenue.
D&A / revenue	6.1%	Depreciation and amortization / revenue.

Growth

Metric	Value	How it is calculated
Revenue growth, 1y	-8.3%	Revenue vs the same period a year earlier. Only from a positive base.
Revenue CAGR, 3y	-4.6%	Compound annual growth of revenue over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Revenue CAGR, 5y	10.0%	Compound annual growth of revenue over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Gross profit growth, 1y	-13.8%	Gross profit vs the same period a year earlier. Only from a positive base.
Gross profit CAGR, 3y	-2.0%	Compound annual growth of gross profit over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Gross profit CAGR, 5y	11.0%	Compound annual growth of gross profit over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating income growth, 1y	-23.9%	Operating income vs the same period a year earlier. Only from a positive base.
Operating income CAGR, 3y	-15.9%	Compound annual growth of operating income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating income CAGR, 5y	3.4%	Compound annual growth of operating income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EBITDA growth, 1y	-17.3%	EBITDA vs the same period a year earlier. Only from a positive base.
EBITDA CAGR, 3y	-11.2%	Compound annual growth of ebitda over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EBITDA CAGR, 5y	9.4%	Compound annual growth of ebitda over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Net income growth, 1y	-23.6%	Net income vs the same period a year earlier. Only from a positive base.
Net income CAGR, 3y	-20.7%	Compound annual growth of net income over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Net income CAGR, 5y	-1.1%	Compound annual growth of net income over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
EPS growth, 1y	-22.4%	EPS vs the same period a year earlier. Only from a positive base.
EPS CAGR, 3y	-19.6%	Compound annual growth of eps over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
EPS CAGR, 5y	-15.1%	Compound annual growth of eps over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Operating cash flow growth, 1y	-9.4%	Operating cash flow vs the same period a year earlier. Only from a positive base.
Operating cash flow CAGR, 3y	16.4%	Compound annual growth of operating cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Operating cash flow CAGR, 5y	6.7%	Compound annual growth of operating cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Free cash flow growth, 1y	-14.9%	Free cash flow vs the same period a year earlier. Only from a positive base.
Free cash flow CAGR, 3y	12.7%	Compound annual growth of free cash flow over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Free cash flow CAGR, 5y	3.8%	Compound annual growth of free cash flow over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Book value growth, 1y	10.4%	Book value vs the same period a year earlier. Only from a positive base.
Book value CAGR, 3y	15.1%	Compound annual growth of book value over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Book value CAGR, 5y	32.4%	Compound annual growth of book value over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Total assets growth, 1y	0.3%	Total assets vs the same period a year earlier. Only from a positive base.
Total assets CAGR, 3y	0.9%	Compound annual growth of total assets over 3 fiscal years: (end / start)^(1/3) - 1. Only when both values are positive.
Total assets CAGR, 5y	8.4%	Compound annual growth of total assets over 5 fiscal years: (end / start)^(1/5) - 1. Only when both values are positive.
Share count change, 1y	-3.5%	Change in diluted weighted shares vs a year earlier. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 3y	-1.6%	Change in diluted weighted shares, per year over 3 years. Negative means buybacks shrank the share count; positive means dilution.
Share count change per year, 5y	16.2%	Change in diluted weighted shares, per year over 5 years. Negative means buybacks shrank the share count; positive means dilution.

Balance sheet health

Metric	Value	How it is calculated
Current ratio	2.94x	Current assets / current liabilities.
Quick ratio	1.90x	(Cash + short-term investments + receivables) / current liabilities.
Cash ratio	1.00x	(Cash + short-term investments) / current liabilities.
Debt / equity	0.95x	Total debt / shareholders' equity. Not shown when equity is negative.
Debt / assets	41.6%	Total debt / total assets.
Liabilities / assets	56.4%	Total liabilities / total assets.
Net debt	$418.0M	Total debt - cash - short-term investments. Negative means more cash than debt.
Net debt / EBITDA	3.01x	Net debt / EBITDA (twelve months), when EBITDA is positive.
Interest coverage	2.54x	Operating income / interest expense.
Working capital	$245.5M	Current assets - current liabilities.
Goodwill and intangibles / assets	59.9%	(Goodwill + intangible assets) / total assets.
Tangible book value	-$213.3M	Shareholders' equity - goodwill - intangible assets.

Efficiency

Metric	Value	How it is calculated
Asset turnover	0.69x	Revenue / average total assets.
Fixed asset turnover	13.6x	Revenue / average property, plant and equipment.
Inventory turnover	10.4x	Cost of revenue / average inventory.
Days inventory	35 days	365 x average inventory / cost of revenue.
Receivables turnover	7.95x	Revenue / average receivables.
Days sales outstanding	46 days	365 x average receivables / revenue.
Days payables	36 days	365 x average accounts payable / cost of revenue.
Cash conversion cycle	45 days	Days inventory + days sales outstanding - days payables.
FCF conversion	248.5%	Free cash flow / net income, when net income is positive.
Capex / operating cash flow	17.8%	Capital expenditures / cash from operations, when that is positive.

Per share

Metric	Value	How it is calculated
EPS, diluted	$0.24	Net income per diluted share, as reported (split-adjusted). Over the last twelve months: the four quarters summed, or net income / latest diluted shares when a quarter has no reported EPS.
Revenue per share	$6.60	Revenue / diluted weighted shares.
FCF per share	$0.60	Free cash flow / diluted weighted shares.
Operating cash flow per share	$0.74	Cash from operations / diluted weighted shares.
Book value per share	$4.19	Shareholders' equity / shares outstanding (diluted weighted shares when not reported).
Tangible book per share	-$1.56	Tangible book value / shares outstanding.
Cash per share	$0.93	(Cash + short-term investments) / shares outstanding.
Buybacks / FCF	22.2%	Share buybacks / free cash flow, when free cash flow is positive.

Valuation

Metric	Value	How it is calculated
Market cap	$574.4M	Share price x shares outstanding.
Enterprise value	$992.4M	Market cap + total debt - cash - short-term investments.
P/E	17.3x	Market cap / net income. Only when net income is positive.
P/S	0.64x	Market cap / revenue.
P/B	1.00x	Market cap / shareholders' equity. Only when equity is positive.
P/FCF	6.96x	Market cap / free cash flow. Only when free cash flow is positive.
P/OCF	5.72x	Market cap / cash from operations, when positive.
EV/Sales	1.10x	Enterprise value / revenue.
EV/EBIT	11.8x	Enterprise value / operating income, when both are positive.
EV/EBITDA	7.15x	Enterprise value / EBITDA, when both are positive.
EV/FCF	12.0x	Enterprise value / free cash flow, when both are positive.
FCF yield	14.4%	Free cash flow / market cap.
Earnings yield	5.8%	Net income / market cap (the inverse of P/E).
Shareholder yield	3.2%	(Dividends paid + share buybacks) / market cap.

What was Janus International Group, Inc.'s revenue in fiscal 2025?

Janus International Group, Inc. reported revenue of $884.2M for fiscal 2025, 8.3% lower than the year before.

Was Janus International Group, Inc. profitable in fiscal 2025?

Yes. Net income was $53.8M, a net margin of 6.1%.

How much free cash flow did Janus International Group, Inc. generate in fiscal 2025?

Cash from operations of $139.5M minus capital expenditures of $25.5M left free cash flow of $114.0M.

Source: SEC EDGAR XBRL company facts. Where a company tags only year-to-date figures, quarters are worked out as differences. Where a line is not tagged it is left empty, never estimated.

Open interactive statements, quarterly figures and charts

Back to Janus International Group, Inc.